North America Psoriasis Treatment Market Size, Share & Industry Analysis, By Drug Class (TNF Inhibitors, Interleukins, and Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, and Others), By Route of Administration (Oral, Parenteral/Systemic, and Topical {Branded and Generics}), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2025-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI109513

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2024
Estimated Year	2025
Forecast Period	2025-2032
Historical Period	2019-2023
Unit	Value (USD billion)
Growth Rate	CAGR of 10.0% from 2025-2032
Segmentation	By Drug Class TNF Inhibitors Interleukins Others
	By Type Plaque Psoriasis Psoriatic Arthritis Others
	By Route Of Administration Oral Parenteral/Systemic Topical Branded Generics
	By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies
	By Country North America (By Drug Class, By Type, By Route of Administration, By Distribution Channel, and By Country) U.S. (By Type) Canada (By Type)